GEN - Genetic Engineering and Biotechnology News

genengnews.com 18 Nov, 2023 02:30 am

Going Dutch: VectorY’s $138M Series A to Advance Vectorized Antibody Programs for Neurodegenerative Diseases

The Dutch company VectorY announced that it had raised one of Europe’s largest Series A rounds of 2023.

categories

Ethnicity Health Science Society Innovation Medical Food Staples

people

Sander Van Deventer Eli Lily

places

Dutch United States Netherlands Amsterdam, Noord-Holland, Netherlands Boston, Massachusetts, United States

organizations

Investment Fund United States Life Sciences Forbion Growth Opportunities Fund Ventures Fund

Read full story at genengnews.com

Red Sea Attacks, The Houthis Are Still Not Terrorists - Victory Girls Blog

I Tried the “Lightest Double-Wheel Suitcase,” and My Friends Couldn’t Believe How Much It Fit

As US pollock quota decision nears, lobbyists and Native groups spar in court

At Guadalajara: Mexico’s Publishers Promote Sustainability, Social Responsibility

Opinion | How Meta can — or can be forced to — avoid addicting kids

Opinion | For democracy to return to Belarus, it will need U.S. help

Opinion | Ridley Scott’s film reignites the debate: Was Napoleon a hero or villain?

Supermarkets under fire for alleged farmed salmon 'greenwashing'

Review | ‘The Boy and the Heron’: A masterpiece for most, middling for Miyazaki

The Best Editor-Tested Mattress Toppers That’ll Make Your Bed Feel Like a Cloud

This Hong Kong Home Has a Gorgeous Outdoor Terrace with Sea Views

Portland Office Welcomes Catharine Buck - Shop VillageSoup

Trump doesn't have 'divine right of kings' to avoid charges in election-subversion case, federal judge rules

Andor season 2 is the only Star Wars show we care about in 2024

How a single word could hold up global talks to save the planet

Semtech Adds Experienced Finance Leader to Board of Directors | Consumer Electronics Net

Opinion | Politicians in both parties need to face up to the national debt

How CEO Can Build Successful Business?

Opinion | Trump’s biggest loss yet: No immunity

I Found an Ingenious (and Free!) Way to Store Holiday Lights

Review | ‘Black TV’ celebrates Richard Pryor, Redd Foxx and other trailblazers

Going Dutch: VectorY’s $138M Series A to Advance Vectorized Antibody Programs for Neurodegenerative Diseases

Drug Candidate’s 'Inside Job' Obstructs Pain Channel, Avoids Side Effects

Cancer Stem Cells Induce Senescence in Macrophages

Pathogen Sequencing Tools Brought to Low Income Countries by Illumina Initiative

Alzheimer's APOE4-Linked Pathology May Be Reduced by APOE-R136S Mutation

Organoids Evolve from Academic Marvel to Industrial Tool

RNA Editing Is Having a Moment

PanOmics-Driven Drug Discovery

Gene Regulation Survey Spans 4,749 Prognostic Modules across 32 Cancer Types

Gene Variant Linked to New Forms of Early-Onset Dystonia, Parkinsonism

Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials Platform

Bloodstream Infection Diagnostics Get Boost from Oxford Nanopore, Day Zero Partnership

Upgrading Phage Therapies to Crush Antimicrobial Resistance

Antibodies Take Center Stage in Alzheimer's

mRNA Vaccines and Therapeutics Combine Power and Finesse

New Generative AI Model Designs Proteins Not Found in Nature

Genetically Engineered Protein Boosts Memory in Animal Models

Wound Healing Fibroblast Dance Led by Fascia-Resident Progenitors

Recombinant Immunotoxin Production in Plants

Icahn Medical School Wins Cancer Discovery & Development Center Grant

Multi-Attribute Quality Control

Machine Learning for Virus Removal

Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin

AstraZeneca Taps Biopharma Expertise to Boost Renewable Energy Efforts

AI Model Weighs Epigenetic Factors to Predict Cancer Outcomes

Fermentation Margins and Cost of Goods

Early-Stage Pancreatic Cancer Diagnostic Funded in Australia

The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease

StockWatch: Verve Investors Accentuate the Negative as Shares Tumble, Then Recover

Graphite Erased: LENZ to Merge with Gene Editing Therapy Developer

Breast Cancer Cells Use Basement Membrane Barrier to Become Invasive

New AI Platform Elucidates Regulatory Activity in the Genome

Patient Cell-Derived Models Point to Therapeutic Options for Mutation-Linked Small Vessel Disease

Cytiva Introduces Novel Protein Purification Technology

Nanoplastics-Brain Protein Interaction Creates Changes Linked to Parkinson’s Disease

Lesser-Known DNA Repair Pathway Pieced Together

Ferrosomes Discovered in C. difficile Offer Novel Therapeutic Target

AI Systems, Given Physical Constraints, Develop Features of Complex Brains

Colonic Organoids Generate Functional Resident Macrophages

Gates Foundation Awards the Malaria Atlas Project $16 Million

Alzheimer's Risk Increased by Microglia Mutation

New Tool, Facemap, Predicts Brain Activity From Mouse’s Facial Movements

“Transformer” Base Editor Safely and Durably Induces Fetal Hemoglobin in Human HSCs

Phlegm-Like Material May Improve Modeling of Cystic Fibrosis Biofilms

Biotech around the World: The West Coast of the United States

Unraveling the Link between Hearing Loss and Dementia

MilliporeSigma Expands Biologics Testing Center in Shanghai

Cellular Mechanics-Based Tool May Help Diagnose Cancerous Cells

Vivodyne's Lab Grown Human Tissue Platform Gets Real with $38 Million Seed Financing

Common Skin Bacterium Acts Directly on Nerve Cells to Trigger Itching

Targeting Cholesterol May Help Treat Alzheimer’s and Related Dementias

Thousands of CRISPR Systems Uncovered with New Search Algorithm

Skin in the Game: Absci Partners with Almirall on Up-to-$650M Dermatology AI Collaboration

AI Identifies Breast Cancer Patients Most Likely to Benefit from Chemo

Canadian Vaccine Development Center Wins NIH Bioprocess Contract

Base Editing Corrects Autism Variant in Mouse Brain

Empowering Spatial Biology Research with Accessible Automated Staining Technology

Case Study: A Trimodal Approach to Interrogate Breast Cancer

Decades of mRNA Research Come to Fruition